Axentis Pharma AG

Ogólne informacje

Axentis Pharma is a specialty pharmaceutical company whose core competence is the combination of a fully patented liposome-based drug delivery technology with already established and well-characterized therapeutic agents. Currently the company exploits its drug delivery technology for the development of AX-TOBRA� inhalable liposomal tobramycin which is delivered directly to the site of infections via standard nebulizers.